human glp 1 Glucagon-like peptide-1 receptor agonism and end-organ protection: Trends in Endocrinology & Metabolism GLP- 1 Agonist Therapy Center
Description
So, I did my research and I decided to go ahead and book an appointment
10.2337/db13-0903 Diabetes 120 OgataH.SeinoY.HaradaN.IidaA.SuzukiK.IzumotoT.et al (2014)
Since its approval for the treatment of diabetes, it has caught the attention of scientists and clinicians alike, as it was noted that patients using this drug for diabetes management also lost weight
Biermann also conceived a study to test the strategy
Insurers cite cost pressures and sustainability concerns
However, these drugs were never originally designed for long-term obesity control
